Table 2.

Disease Characteristics of Murine CML

MouseLatency (wks)WBCDifferential CountSpleen Weight (g)
Grb2 − 15 45P/50L/5M 0.2 
H20 75 84P/5L/3M/6NR 0.6 
H21 100 73P/11L/1M/11NR 0.8 
H22 77 69P/7L/3M/9NR 0.6 
H23 77 80P/7L/2M/1NR 0.6 
H24 36 51P/9L/1M/36NR/3Blasts 0.7 
H25 265 86P/2L/1M/11NR 0.9 
H26 250 90P/3L/2M/1NR 0.75 
H27 53 ND 0.6 
H28 220 79P/13L/3M/5NR 0.8 
H29 200 76P/4L/20NR 0.85 
MouseLatency (wks)WBCDifferential CountSpleen Weight (g)
Grb2 − 15 45P/50L/5M 0.2 
H20 75 84P/5L/3M/6NR 0.6 
H21 100 73P/11L/1M/11NR 0.8 
H22 77 69P/7L/3M/9NR 0.6 
H23 77 80P/7L/2M/1NR 0.6 
H24 36 51P/9L/1M/36NR/3Blasts 0.7 
H25 265 86P/2L/1M/11NR 0.9 
H26 250 90P/3L/2M/1NR 0.75 
H27 53 ND 0.6 
H28 220 79P/13L/3M/5NR 0.8 
H29 200 76P/4L/20NR 0.85 

Characteristics of the P210-induced myeloproliferative disease in one transplant experiment. Disease was induced by transduction with MSCV 210 (see Table 1). Grb2 is a mouse that received MSCV Grb2, which only expresses grb2. This mouse (as did all MSCV Grb2 mice) remained healthy for the entire 9-month observation period. WBC count is 106 cells/mL. For the differential counts, P indicates polymorphonuclear granulocytes, L indicates lymphocytes, M indicates monocytes, NR indicates nucleated red blood cells, and ND indicates not determined.

Close Modal

or Create an Account

Close Modal
Close Modal